# Author Interview - Professor Andrew Cope, 2026

Page: https://stenobird.com/podcast/the-imid-forum-981476/author-interview-professor-andrew-cope-2026
Text version: https://stenobird.com/podcast/the-imid-forum-981476/author-interview-professor-andrew-cope-2026.md
Podcast: [The IMID Forum](https://stenobird.com/podcast/the-imid-forum-981476)
Published: 2026-03-05T11:30:56+00:00
Episode link: https://soundcloud.com/imidforum/author-interview-professor
Audio file: https://feeds.soundcloud.com/stream/2277812666-imidforum-author-interview-professor.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/the-imid-forum-981476/episodes/author-interview-professor-andrew-cope-2026
Duration seconds: 1490

## Resource

Join Professor Peter Nash from the Griffith University in Brisbane, and Professor Andrew Cope from the Centre for Rheumatic Diseases, King’s College London, London, UK, as they discuss his recent paper ‘Long-term outcomes of abatacept in individuals at risk of developing rheumatoid arthritis (ALTO): a randomised, double-blind, placebo-controlled trial’.

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/the-imid-forum-981476/episodes/author-interview-professor-andrew-cope-2026/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/the-imid-forum-981476/author-interview-professor-andrew-cope-2026.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.